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"Cancer has been defined by Willis 93 as an abnormal mass 
of tissue, the growth of which exceeds and is uncoordinated 
with that of norm.al tissues, and persists in the same exces-
sive manner after the cessation of the stimuli which evoked 
the change." 
"Cancer is a disease of the cell that is transferred to 
the descendants of the cell. The disease is recognized by the 
behavior· of a population of abnormal cells within a normal 
tissue, as manifested by varying degrees of morphologic dis-
orientation, aggressive growth and invasion, with ultimate 
destruction of the normal cell population."1 
"Cancer is a generic term for a variety of malignant 
neoplasma, due to unknown and probable multiple causes, a-
rising in all tissues composed of potentially dividing cells, 
in man and other animals, and resulting in adverse effects on 
the host through invasive growth and metastases. It is one 
' ' 
of the major causes of death throughout the world. In the 
United States, deaths from' cancer are second only to cardio-
vascular and renal diseases. Wherever malnutrition and other 
socioeconomic factors, as well as infectious diseases, etc., 
result in a short average span of life, cancer is not an im-
portant health problem, in spite of increase in population. 
Conversely, an increase of population that is associated with 
an increase in life expectancy does bring a progressive in= 
crease in the occurrence of oancero Thus, the inevitable 
2 
paradox: as public health improves, cancer becomes a greater 
problemo 2 
The progressive increase in the number of reported deaths 
from cancer is, to a large extent, only apparent, for more 
oases are being diagnosed accurately as the public and the 
medical profession become cancer conscious and as more accu-
rate methods for diagnosis become available. The mortality 
from cancer is also due to an increase,.in the numbers of in-
dividuals reaching advanced age. In the.United States there 
were 13 million persons 45 years of age or older in 1900; by 
1948 there were 39 million persons .1n,tbat age group and in 
1958 there were 50 million. In view of the fact that cancer 
is prevalent among aged individuals, cancer cases may continue 
to increase in the United States !'or a number of years on the 
basis of these !'acts alone. In addition, there appears to be 
a true increased incidence of certain forms of cancer. 
The outstanding recent changes in cancer morbidity and 
mortality are as followsg (1) a threefold increase in cancer 
of the lung among males, (2) a twofold increase in leukemias 
and "lymphomas,u (3) a 30% decrease in cancer of the stomach, 
and (4) a 30% decrease in cancer of the cervix. Also, the 
gap among the greater probability of cancer in females and 
the lesser one in males bas been closing due mainly to the 
increase in pulmonary cancer in men. More than half of the 
3 
cancer risk in men is due to oanoer of the skin, prostrate, 
lung, stomach, and intestine, whereas more than half of the 
cancer risk in women is due to cancer of-the breast, intestine, 
skin, and cervix uteri. During a lifetime one in every four 
women and one in every five men maf be expected to develop 
cancer. The increased risk is due in part to the decline of 
noncancerous causes of death."3 
2. Chemotherapy of Neoplastic Disease 
"Although great strides have been made in the chemotherapy 
of neoplastic disease, the sobering fact must be realized that, 
after the diagnosis has been made, only 20 per cent of all 
patients are salvaged for five years by currently available 
therapeutic measures. Inasmuch as surgery and radiotherapy 
have been developed to a high degree of perfection, it is 
obvious that major advances must be sought in other fields. 
Methods for early diagnosis and effective chemotherapy could 
obviously make great contributions. 
It should be stated at the onset that, with the exception 
of early childhood leukemia (which can be cured by folio acid 
antagonists), no chemical compound bas yet been found which is 
I 
capable of curing any form of cancer~ However, various drugs 
and hormones are available which can induce temporary remissions 
in certain types of neoplastic disease. Other agents are of 
value in that they appear to support the host against the 
ravages of the disease. Drugs capable of inducing temporary 
4 
remissions can be divided into three classes. (1) Cytotoxic 
agents which exert their actions by virtue of their chemical 
properties: as a group these compounds lack selectivity of 
action in that they are toxic to normal as well as malignant 
cells. However, they are of some therapeutic value inasmuch 
as the vulnerability of cells appears to be related to their 
rate of mitotic activity. (2) Cytotoxic agents which exert 
their actions by virtue of their physical properties: this 
group comprises the radioactive isotopes, which exert their 
effects through ionizing radiation •. Radioactive isotopes also 
lack selectivity of action, but in a few .. instances advantage 
can be taken of the selective distribution of a particular 
element in the body to attain relatively high concentrations 
at a desired site. (3) Agents which exert their action by 
altering the environment of the cancer cell: this group com-
prises certain hormones, notably estrogens, androgens, and 
adrenocortical steroids. Altering the hormonal environment 
with respect to estrogens and androgens is of some value in 
the control of neoplasms of the secondary sex organs. Induced 
hypercorticism provides an unfavorable environment for certain 
malignant growths involving hematopoietic tissue."45 
5 
Purpose and Soope of the Research 
In August, 1965 Andrew Bachmann presented a tlwsis based 
on the fact that indole was selectively absorbed in the cancer 
tissue. This paper is similar in that indole is used as the 
means of transport to concentrate the alkylating agents in the 
tumor. The alkylating agents presented in this paper are ep-
oxides and methane sulfonateso 
The historical portion of this paper is designed to show 
the value of epoxides and methane sulfonates in chemotherapy. 
The experimental portion is composed of the synthesis of these 
com.pounds, related intermediates, and a new color test which 
is a potential method for the detection of indole in a tum.or. 
HISTORY 
Evidence for the Association of Indole 
With Tumor Cells 
"Indole has been tested for its anti-cancer properties 
and found lacking. However, it was found that lipotropic 
materials such as amytol, phentothal, Br3ccH20H, chloretone 
6 
and indole, which greatly inhibit brain respiration, also 
markedly inhibit the respiration of Erlich Ascites tumor cells. 
These compounds inhibit the intake of glycine into these cells 
under anaerobic conditions in the presence of glucose, the ex-
tent of inhibition being greater than that of anaerobic gly-
colysis. It is suggested that respiratory mechanisms and the 
transport system of the whole cell depend for their activities 
on the lipid components of the cell membrane structures with 
which these lipotropic agents become associated, thereby de-
creasing these activities."15 
Review of Related Work from 
Potential Neoplasm Inhibitors I 
A suspension of indole containing radioactive c14 was 
administered to a female C3H mouse by intraperitoneal injection 
by Bachmann and the following data were collected. Bachmann 
found about a 17:1 concentration ratio of indole in cancer 
tissue as opposed to similar muscle tissue. The indole con-
centration remained at a high level for about twelve (12) hours. 
7 
Then over the next seventy-two (72) hours$ the indole appeared 
to be removed and detoxified by the liver. 
The fact that the indole content of the corresponding 
muscle tissue was always so small indicated that the pH induc-
tion of the tumor had indeed been used to cause a selective 
deposition. To Bachmann•s knowledge, this was the first instance 
that such an effect had been observed. 
"Nitrogen mustards and alkyl methanesulfonates will react 
with the hydrophobic constituents of a living cell in con-
siderably less than twelve (12) hours, which is the time limit 
for the maximum concentration of indole. Therefore, the indole 
moiety should act as an effective transport molecule for alkyl-
ating substituent should combine with the cell wall, if indole 
concentrates there, and change its character enough to inhibit 
cell respiration~ thereby killing the cell through respiration 
failure. If indole concentrates elsewhere in the cell, the 
alkylating substituent should interrupt metabolic pathways 
resulting in the death of the cell.'' 
Bachmann also suggested that if a gamma ray emitter were 
placed upon an indole molecule, the resulting molecule might 
serve as a locator for tum.ors. To investigate this idea, 
5-iodoindole was synthesized which contained iodine-125~ Though 
encouraging, data on this experiment was not conclusive. 16 
17 51 Influence of pH on Reactivityg ' 
8 
"In Warburg 1s studies on tumors .11 the observation was made 
that, whereas both normal and tumor tissues produced lactic 
acid from glucose or glycogen in the absence of oxygen, practi-
cally only cancer tissue showed the ability to produce lactic 
acid from glucose in the presence of oxygen. 
The respiration ratio of cancer and of normal tissues 
appeared to be very nearly of the same order of magnitude, 
and to account for the high aerobic glycolyais in tumors 
Warburg postulated that the respiratory mechanism is such 
tissues was damaged as a result of the neoplastic transfor-
mation. High anaerobic glycolysis appeared to be a general 
property of growing or multiplying tissues, since it was 
found in embryo tissue and testes, but in these normal tissue 
glyoolysis was largely abolished by the presence of oxygen. 
In most tumors, the high anaerobic glycolysis was relatively 
little reduced when oxygen was admitted to the system. 
That lactic acid is actually produced from tumors was 
shown by several investigators who observed that the venous 
blood leaving a ttllllor contained less glucose and more lactate 
than did venous blood in a comparable tumor-free site in the 
same animal. 
Since lactic acid is a relatively strong organic acid, 
its accumulation within the tumor should produce a lowering 
of the pH, provided that the rate of glycolysis exceeds both 
9 
the diffusion of buffers from the arterial oirculation into 
the cells and provided that the rate of S1!lpply of the glucose 
to the cells is sufficiently high. 
By inserting electrodes directly into the tumor mass of 
the living animal, Voegtlin et !.! demonstrated that the admini-
stration of glucose, whether subcutaneous or intraperitoneal, 
was followed very quickly by a drop in pH of 0.4 to 0.6 unit. 
The pH of the tumor may drop from 6.9 to 6.3 without the occur-
rence of any pulmonary respiratory symptoms indicative of sys-
tematic acidosis, thus indicating that the increased acid pro-
duction is largely confined to the tumor and that the excess 
lactate carried off in the venous circulation is quickly meta-
bolized by the normal tissues. 
Kahler and Robertson compared the hydrogen ion concen-
tration of the liver and of a transplanted heptoma in fasted 
rats. The pH of the liver was 7.4, that of the tumor 7.0. 
When the rats were supplied with excess glucose, the pH of 





There are two (2) possible mechanisms by which an epoxide 
can react with a nucleophilic centre (A=) in neutral solution. 
_..+_A_-->~ R•CH°CH A Slow /?" I 2 
o-
The first is a unimolecular process which would only be 
favored if the terminal carbon atom were substituted, and the 
second is a typical Sn2 substitution as shown above. 74 
The Sn2 mechanism may be explained more clearly by the 
following: 
x- + R-Y 
---->'!'I> R-X + Y-
IJ.he complete separation of R and Y does not occur, but a 
transition state occurs in which R is loosely combined with both 
X and Y. The attainment of the transition state is also assisted 
by solvation of the polar complex and in the subsequent process 
desolvation, charge transfer, and bond formation are involved. 
Effectively a carbonium ion R+ is again trana~erred from Y to 
X but in this case it is at no time free in the sense of being 
detached from Y, for the bond forming and bond breaking pro-
cesses occur simultaneously. In the rate determining formation 
of the transition complex two molecules are undergoing covalenoy 
change. A feature of the Sn2 reaction is that the rate is de-
pendent on the concentration of the displacing group x- and upon 
11 
its affinity for the electrophilic R+. The driving force is 
the attack of the nucleophilic group x- on a carbon atom in 
the R group of the alkylating agent and the extent of the re-
action will depend on the ~elative nucleophilic capacities 
of groups x- and Y-. 72 
Epoxides are relatively slow to react~ the half-life of 
diepoxybutane is about 100 hours at 37°c in purely aqueous 
solution. The reaction rate.will be increased by the presence 
of reacting groups, since for terminally unsubstituted deri-
vatives the Sn2 mechanism operates. Actually, only terminally 
unsubstituted compounds are of interest biologically. We thus 
have a group of moderately reactive alkylating agents which 
are effective under biological conditions and which are trans-
ported as neutral molecules; the rate of reaction will depend 
on the concentration of reacting centres. 
The reagents which react by the Sn2 route can be removed 
quickly at sites of high nucleophilic potential. The virtue 
of the slower reacting epoxides may be that they survive long 
enough to alkylate target sites at distant regions. Henry, 
Rose, and Walpole {1950) suggested that cytotoxic alkylating 
agents polymerize in ~' giving a structure containing 
reactive groups which are spaced at approximately 7.62 apart. 
This repeat distance is similar to that of the side chains 
in a fully extended protein or the internucleotides in a nucleic 
acid. Multipoint attachment of the polymer to either of these 
macromolecules in a chromosome structure was thought to be 
12 
responsible for the induced mitotic abnormalities. ~ 
Effect of pH on Reactivity of Epoxides 
Some simple epoxides have a high rate coefficient for 
acid catalysed type of reaction. This type of compound would 
be expected to react more readily with nu~leophilio centres in 
regions where the acidity is relatively higher. For those 
groups with pKa somewhat removed from physiological pH, such 
as phosphate groups, carboxyl groups~ and relatively weak basic 
groups, the effect of the limited pH change on ionization will 
not be significant. 
A careful study of certain basic diepoxide derivatives 
by Gerzon et !1_. (1959) has shown how another structural modi-
fication may be introduced in order to obtain acid-enhanced 
reactivity. Ross (1950) had shown that the incorporation of 
a charge onto the nitrogen atom of the methiodide of N,N-ai-
(2,J-epoxypropyl)-p-anisidine enhances the reactivity of the 
epoxide ring. This effect is independant of the rate enhancing 
effect of pH change alone. Some correlation between basicity, 
rate of reaction with phosphate ion, and antileukemic activity 
was established by Garzon!..:!! !1_. (1959) and it would seem pro-
fitable to extend the study of these basic epoxides to the treat-




Effects on Protein Synthesis and on Respiration 
Butadiene dioxide inhibited the .!!! vitro incorporation 
of glycine-1-c14 into the proteins of Ehrlich ascites carci-
noma cells but had no effect upon the rate of respirationo33 
Reactions With Proteins and Compounds Containing 
Functional groups That Occur in Proteins 
It bas been shown that epoxides can react with various 
proteins including casein, 19 egg albumin,43 bovine serum 
albumin,4 161718 B- lactoglobulin,43 wool, and human hair.30 
Tests for functional groups of the proteins showed that alkyl-
ation of the following types of groups occurred: Carboxyl,5,7 
phenolic,43 amino, 61 7,43 imidazole6,7 and sulfhydryl.6 Ep-
oxides reacted with esters of amino acias58 to yield disubsti-
tuted amino compounds58 and lactones.59 Reaction with thio-
amides and thiols yielded 2-bydroxy-alkyl sulfides34 and reaction 
with pectic acid resulted in esterification.36 Thus, reaction 
can occur with a variety of groups occurring in proteins, and 
if polyepoxides are used, cross-linking of proteins may 
occur.4,a,42 Very little deactivation of cholinesterase 
occurred, bowever. 27 
Cytologic and Mutagenic Effects 
Glycidol caused chromosomal bridging and breakage in 
cultured S-180 ce1120 and the administration of butadiene 
dioxide to male mice interfered with spermatogenesis and caused 
chromosome breaks. 66 Epoxides have been shown to be effective 
mutagens in a variety of biological systems including 
Drosophila Melanogaster, 22 , 23 Neurospora crassa,57, 61 
Penicillium Chrypogenum,54 Escherichia coli, 87 and tomatoes.41 
Reactions With Nucleic Acids and Nucleic Acid Moieties 
Bifunctional epoxides reacted with nucleoproteins in 
solution to cause the formation of a gel, and the alkylation 
occurred exclusively with the DNA portions of the molecules7,ll,l2 
This gel formation was probably the result of cross-linking of 
DNA molecules. There is some evidence that alkylation of both 
nucleoprotein7 and DNA9 occurred at the phosphate groups with 
the resulting formation of esters. These esters might in turn 
alkylate the ring-nitrogen atoms of _the purines, which resulted 
eventually in scission of the ribose-phosphate chain of the 
DNA.9 Treatment of guanosine with ethylene oxide and propylene 
oxide in unbuffered solution at 37°c yielded a product that was 
spectrally similar to 7-methylguanosine. 63 Treatment of tobacco 
mosaic virus RNA with ethylene oxide or propylene oxide caused 
deactivation of the reconstttuted virus,44,45 when as few as 
1-3 molecules of the epoxide had reacted with one molecule of 
the RNA, and it appeared that the guanine moieties were the 
chief sites of reaction.44 
15 
Effects on Fertility 
Fahmy and Fahmy (1958) have made related studies on the 
action of different alkylating agents on different stages of 
cell development in the germinal tissue of Drosophila males. 
The adult males were injected with the agent and the germ line 
was fractionated by repeated matings to a succession of virgin 
females. The mutation rate fluctuated in successive broods. 
It is believed that since the sperm used in the sequential 
matings time of treatment, the variation in brood mutation 
response probably reflected the relative.susceptibility of 
the various cell stages to the action of the mutagenic alkyl-
ating agents. 
Diepoxides and most simple mustards produce a maximum 
effect on early spermatids and little action on spermatocytes 
and spermatagonia.78 
2) Methanesulphonates73,B7 
Esters of alkanesulfonic and arenesulfonic acids are 
alkylating agents because in reaction the alkyl-oxygen bond 
undergoes fission. Methyl esters react with nucleophilic 
centres by a bimolecular mechanism previously discussed in 
this paper. 82 Therefore, the chemical reactions of the sulfonic 
esters are generally similar to those of the epoxides. 
In the series CH3so2o(CH2) 0oso2cH3 , the chemical reactivity 
is low in compounds (n=2 and 3) due to the mutual deactivating 
effect of the methanesulfoxy groups. From n=4 upwards the 
76 
chemical reactivity is higher and more uniform. 
Distribution and Fate of Administered Sulfonic Esters 
16 
The compound, s35 - labeled tetramethylene ester of 
methanesulfonic acid was administered to rats, mice and rabbits 
and the data were collected. In the rat there was some selec-
tive concentration of the s35 in the spleen and bone marrow, 
but 32 hours after injection, 95 per cent of the s35 was present 
in the urine. Small amounts of s35 were associated with the 
liver proteins. Following the administration of this agent 
to humans the s35 disappeared rapidly from the blood and 45-69 
per cent of the s35 was present in the urine in 48 hours.68,69 
Tetramethylene ester of methanesulfonic acid labeled with 
c14 in the 1 and 4 positions was also injected into rats and 
the data were collected. The specific activities of the kidneys, 
lungs, and liver were higher than those of the other tissues 
examined, and in the liver only small amounts of radioactivity 
were associated with proteins, fats and sodium nucleates. 
Within 24 hours 12-14 per cent of the injected c14 was excreted 
as carbon dioxide, 22-36 per cent was in the urine, and 3-8 per 
cent was in the feces.83,89 
Effects on Glycolysis and Respiration 
1,9-Di-(methanesulfonxy) nonane depressed the respiration 
of ascites~tumor\cells'.and promoted aerobic glycolysis 60~80 
17 
per cent but had no influence or anaerobic glycolysis.39 Several 
other methanesulfonyl esters acted similar. Kinetic studies 
with enzymes led to the conclusion that the inhibition of res-
piration by beta-chloroethyl methanesulfonate was chiefly due 
to physical effects of this agent upon the hydrogen transport 
chain of the cell. 25 
Effects on Protein Synthesis 
The majority of the esters of methanesulfonic acid had 
little or no significant effect on protein synthesis. 
Deactivation of Enzymes 
Several methanesulfonic esters had very littl~ anti-
cholinesterase activity, 27 but tetramethylene ester of methane-
sulfonic acid inhibited crystalline triosephosphate dehydro-
genase. 55 
Reactions With Proteins and With Compounds Containing 
Functional Groups that Occur in Proteins 
Evidence has been obtained that tetramethylene ester of 
methane-sulfonic acid can react with the protein portion of 
nucleoproteins,28 and several meth11nesulfonic esters reacted 
with the mercapto groups of denatured egg albumin and with 
carboxyl and imidazole groups but not the amino groups of 
bovine serum albumin. 6'7 The reactions possibly cause dethio-
18 
lation of proteins, but the biological significance of such 
dethiolation is not yet known. 
Antimitotic, Cytologic, and Mutagenic Effects 
Tetramethylene ester of methanesulfonic acid inhibited 
the mitosis of cultured fibroblasts, 31 ' 32 ,46 and 1,4-dimethyl-
tetramethylene ester of methanesulfonic acid inhibited cultured 
11 leukemia cells. Experiments with tetramethylene ester of 
methanesulfonic acid and tritiated thymidine showed that synthesis 
of SNA by fibroblasts could occur even when the mitotic activity 
was reduced.3l,32 Among the cytologic effects noted for the 
tetramethylene and 1,4-dimethyltetramethylene esters of 
methanesulfonic acid on mannnalian cells were giant cell for-
mation, 10 nuclear enlargement,46 multinucleation32 ' 35 chromosome 
46 46,37 br~aks, and chromosome bridges. Concerning the mutagenic 
effect, it is of interest that radioactivity was detected in the 
testicles of mice following the injection of 1,4-dimethyltetra-
methylene ester of methanesulfonic acid. 
Effects in Synthesis of Nucleic Acids 
Tetramethylene ester of methanesulfonic acid had only a 
slight or no inhibitory effect upon the de B.Q.Y£ synthesis of 
nucleic acid purines. The lack of inhibition of the synthesis 
of nucleic acids is consistent with the observation that the 
incorporation of tritiated thymidene into the nuclei of cultured 
19 
cells in the presence of tetramethylene ester of methanesulfonic 
acid occurred even after mitotic activity was greatly reducea.3l,32 
Reaction With Nucleic Acids and Nucleic Acid Moieties 
After treatment with tritiated tetramethylene ester of 
methanesulfonic acid, tritium was found localized in the nuclei 
of the root tips of Vicia ~, whereas no tritium was detected 
in the cytoplasm. 67 
There is also evidence that sulfonic esters can react with 
DNA in vitro. Alkylation of DNA with methyl methanesulfonate 
and with ethyl methanesulfonate caused an immediate decrease in 
viscosity of the solution, perhaps because the DNA molecules 
become more highly coiled. It was suggested that the initial 
site of alkylation might be the phosphate groups of the DNA 
with subsequent alkylation of the purine-ring nitrogen atoms 
by the tri-esters; alkylation of the purines could then result 
in expulsion of the quaternized purine and rupture of the 
9 desoxyribosephosphate chain. 
1. 
Preparations and Reactions 
of ·Related Compounds 
20 
38 18 40 Reactions cf Epichlorohydrin with Secondary Amines ' ' 
(1) Secondary amines react readily with excess 
epichlorohydrin to yield mainly amino chlorohydrin 
as indicated below: 
With alkali, the epoxy ring is closed to yield an 
epihydrinamine as shown below: 
The latter products condense with another secondary 
amine to yield unsymmetrical 1,3-diamino-2-propanol 
according to the following equation: 
2. Preparations of Methane Sulfonates 
There are three general methods for the preparation of 
methanesulfonates. 
(1) Refluxing methane sulfonyl chloride with an alcohol, 
or reacting in pyridine.79 
(2) Refluxing an alcohol with methane sulfonic acid 
to give poor yields. 13 
ROH + + HOH 
21 
(3) Refluxing the silver salt of methane sulfonic acid 
with an alkyl chloride.47,86 
3. Mannich Reaction 
(1) The beta or 3-pos~tion in indole is very reactive and 
with formaldehyde and dimethylamine in the presence of 
acetic acid undergoes the Mannich reaction to form the 








(2) The study of reaction of chromones--with formaidehyde 
and a secondary amine hydrochloride by the Mannich 
reaction. 92 
R=methoxy, alkyl, halog~n or hydrogen 
R' =Alkyl 
4. Schiff Base49,5o 
5. 
(1) The conversion of a primary amine into an aldimine by 
condensation with an aldehyde. 
R = Phenyl and Aliphatic 
(2) Preparation of a ketimine by reaction of a primary 
amine with a ketone. 
Rt 
RNH + ':c=o 
2 RY 
Reduction of Schiff Bases 






with Sodium Borohydride ' 
H Ar-C~N-Arl 
Where Ar and Ar1 may be a phenyl group or a nitro-, 
ohloro-, methoxy-, or hydroxyphenyl group. 
(2) 
23 
The yields range from 81-90% and the reduction condition 
aren•t too critical. It was found, however, that the 
reaction proceeded more readily in ethanol than+meth0anol. -~ i-
PhCH=N-CH3 MeOH ) PhCH2-N-CH HCl :):i PhCh2-N-CH3 oo H 3 I 
NaBH4 H 
The mixture comes to room temperature and is then heated 
for two (2) hours at 50°. The methanol is removed and 
product extracted with ether. The hydrochloride is 
formed by treating with HCl gas. 
Previous Color Methods for the Detection of Indole 
Several color tests have been developed for the detection 
of indole derivatives. These include a test which employs a 
color reaction between indole and a eerie nitrate reagent by 
Hartough.52 Anger and Ofri describe a reaction test, yielding 
a red color, by reaction of an indole derivative with pyridyl-
pyridinium chloride. 14 Sawicki obtained a blue color by reaction 
of 3-meth11-2-benzothiazolone with indole. 83 The indole ring in 
reserpine was detected by Haycock and Mader by reaction with 
dilute nitrous acid.53 When heated with Arreguine's reagent 
(glacial acetic acid, concentrated hJdrochloric acid, and 
:mn:tbydrol) a color reaction is given by indole. 84 A test using 
a chloroform solution of piperonal, phosphorous pentachloride, 
and trifluoroacetic acid bas also been used.71 
24 
Discussion and Experimental 
In the present study it was found that butyl nitritej 
acidified with concentrated hydrochloric acid, gave a color 
reaction test for indole and many indole derivatives. 
Early in this work it was found ·that the test is sensitive 
for indole in the presence of freshly dissected liver, stomach, 
and kidney of a normal mouse. Repetition of the test with a 
cancerous mouse showed that after twenty (20) hours the indole 
was concentrated in the tumor, and it was not detected in the 
liver or kidney. 
The procedure using normal mice is described below: 
To a solution of 6.5ml of polyethylene glycol (PEG-300) 
was added 100 mg of indole and 5.5 ml of sterile glucose 
solution. A 0.5 ml sample was taken from this solution and 
injected into the abdomen of each of two (2) normal mice 
which had been previously starved for two (2) hours. 
One of the mice became a little sick and was sacrificed 
(chloroform) after one-half hour. The liver, stomach, and 
kidneys were removed, placed in three (3) separate beakers, 
each containing 50 ml of ether. The tissues were crushed, 
removed from the extract, and the ether evaporated to near 
dryness by means of a hot-water bath. The test for indole 
was made by dissolving the residue in 5 ml of ethanol and 
adding two (2) drops each of butyl nitrite and concentrated 
hydrochloric acid. 
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Results of Test on First Mouse: 
Liver Negative, no color was observed. 
Stomach Negative, no color was observed. 
Kidney Negative, no color was observed. 
When no test was given for indole, the remainder of the 
mouse was placed in a beaker and extracted with 100 ml of 
ether. The ether was evaporated and the color test was 
repeated. 
Results: 
Body cavity of the mouse --- A positive test {red color) 
was obtained. 
Two (2) hours after the injection, the second mouse was 
sacrificed (chloroform) and dissected. The kidney, liver, and 
stomach were removed and placed in three (3) separate beakers, 
each containing 50 ml of ether. The tissues were crushed and 
removed from the ether extract. The ether was then evaporated 
to near dryness on a hot-water bath and the residue dissolved 
in ethanol. The solution was tested using butyl nitrite and 




Positive, a red color was observed. 
Positive, a red color was observed. 
Stomach Positive, a red color was observed. 
Since the test showed that indole can be found in the 
dissected organs of a normal mouse, it was decided to repeat 
the test with cancerous mice. The procedure is described 
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as follows: 
To a solution of 6.5 ml of polyethylene glycol (PEG-300) 
was added 100 mg of indole and 5.5 ml of sterile saturated 
aqueous solution. A 0.5 ml sample was taken from this 
solution and was administered to cancerous C3H mouse which 
had been previously starved for two (2) hours. After a period 
of thirty (30) minutes, another cancerous C3H mouse was injecetd 
using the same procedure as described above. 
The first mouse died approximately one-half hour after 
injection. The mouse was dissected; the liver, kidney, tumor 
and corresponding muscle tissues were removed, extracted with 
ether, and tested using the butyl nitrite-hydrochloric acid 
test. The results are shown below: 
Tumor Negative, no color was observed. 
Kidney Negative, no color was observed. 
Liver Negative, no color was observed. 
Muscle Negative, no color was observed. 
After a period of twenty (20) hours, the second mouse was 
sacrificed (chloroform) and dissect.ad. The kidney, liver, tumor, 
and corresponding muscle tissue were removed, extracted, and 
tested using the butyl nitrite-hydrochloric acid test. The 




Positive, an orange-red color was observed. 
Negative, no color was observed. 
Negative, no color was observed. 
Muscle tissue - Negative, no color was observed. 
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Since indole was shown, by the butyl nitrite-hydrochloric 
acid test, to concentrate in cancerous tissue in mice, several 
derivatives of indole and of related compounds were purchased 
or prepared for this study. 
Initially, it was planned to teat each compound purchased 
or prepared in a cancerous mouse, and a few were test~d. However, 
the butyl nitrite-hydrochloric acid test offered such a rapid, 
convenient. and inexpensive method to test indole and related 
compounds, in vitro, it was employed as a guide to predict 
.whe.ther or not these particular compounds should be used in 
the animal test. 
The following compounds were prepared for injection into 
cancerous mice. 
H 
To 3.92 grams (0.02 mole} of tryptamine hydrochloride 
was added 50 ml of water and 20 ml of 95% ethanol. The reaction 
mixture was stirred, warmed and made distinctively basic by the 
addition of a saturated solution of potassium carbonate. The 
oily layer which separated was extracted into 40 ml of ether. 
The ether solution was added dropwise to 3.79g (0.042 mole) of 
epiohlorohydrin in 20 ml of 95% ethanol. The mixture was allowed 
to stand overnight. 
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The reaction mixture was diluted with 250 ml of water, 
then treated with 100 ml of ether and 10 ml of glacial acetic 
aoid. The upper layer was extracted with 100 ml of 10% acetic 
acid, and the aqueous acetic acid portions were combined and 
treated with excess 6X sodium hydroxide solution. The oily 
layer which separated was taken up in 100 ml of ether. The 
ether extract was filtered and treated with approximately 12 
grams of sodium hydroxide pellets. After three (3) days in the 
refrigerator and the addition of 125 ml of ether, the solvent was 
filter,ad, the ether evapora-ted·on a bot-water bath, and· the residue 
wa~.left overnight in a flask·!n a vacuum desicator. The yield of 
clear oil was 1.70 grams .t33%.yield). Calculated for c16n20N202g 
titrateable N, 5.50%. Found, 4.9%. 




To l.81 grams (O.Ol mole) of tryptamine hydrochloride 
was added 20 ml of water and 10 ml of 95% ethanol. The reaction 
mixture was warmed, stirred, and made distinctively basic by 
the addition of a saturated solution of potassium carbonate. 
The oily layer which separated was extracted into 40 ml of 
ether. The ether and ethanol were removed by means of a rotary 
evaporator, the residue dissolved in 5 ml of absolute methanol 
and added to 0.61 gram (0.005 mole) of propane sultone dissolved 
in 10 ml of absolute methanol. The reaction mixture was allowed 
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to stand at room temperature for three (3) days. The ether 
and ethanol were removed by means of a rotary evaporator. To 
the product (3.6 grams) was added 10 ml of methanol, and the 
mixture was warmed. Then, 14.5 ml of O.lN sodium methoxide 
( 0.115 g of sodium metal in 50 ml MeOH) was added; the mixtux•e 
was swirled and cooled in an ice-water bath. A crystalline 
product could not be obtained; therefore, the mixture was 
triturated with ether. An oily, sticky product was obtained. 
The ether and water were decanted oft;, and the product was dried 
in a flask in a vacuum desicator. The yield of the oil was 
1.22 grams (40% yield). Calculated for c13H17No3sNa: 
tritrateable N, 4.60%. Found 4.2%. 
Methyl-2-furylmethyl-2,J-epoxypropyl amine 
To a three-necked liter flask with a thermometer and 
mechanical stirrer attached was added 27.75 g (0.3 mole) of 
epichlorohydrin. The flask was placed in an ice bucket and 
cooled to 4°c. From a dropping funnel 33.3g (0.3 mole) of 
N-methylfurfuryl amine was added slowly, keeping the temperature 
below 30°c. To catalyze the reaction, approximately 0.5ml of 
water was added. The reaction mixture was stirred, and the 
temperature kept below 30°c for one and one-half hours. The 
mixture was then cooled to 10°, and 16 g (0.4 mole) of sodium 
hydroxide in 25 ml of water was added batchwise, keeping the 
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0 temperature below 25 . The reaction mixture was then extracted 
I 
I 
with three (~) 150 ml portions of ether, the three (3) ether 
portions combined, placed over sodium hydroxide pellets, and 
left to stand in the refrigerator overnight. 
The mixture was filtered by gravity and the ether removed 
by means of a rotary evaporator, without heat. The.mixture was 
0 
then distilled under reduced pressure (J5mm), ~p 145-80 • 
The yield of clear oil was 30.88g (61.4% yield). Calculated 
for c9H13No2 : tritrateable N, 8.38%. Found 8.22%. 
2-Furylmethyl-bis(2,3-epoxypropyl)amine 
0 CH2-N(CH2-c'-\rn2>2 
To a three-necked liter flask with a thermometer and 
mechanical ~tirrer attached was added 55.5g (0.6 moie) of 
epichlorohydrin. The flask was piaced in an ice bucket and cooled 
tor:•4°o From.a.funnel 29.1 g (0.03 mole) of furfuryl amine was 
added slowly with stirring and cooling, keeping the temperature 
below 30°0. Approximately 0.5ml of water was added to catalyze 
the reaction. The mixture was stirred overnight and left to 
stand over the week-end. 
The mixture was stirred again, cooled to l0°c,apd J2g 
(0.8 mole) of sodium hydroxide in 60 ml of water was added 
batchwise, keeping the temperature below 20°. After one hour 
of mixing, the reactiop mixture was diluted with 100 ml of 
water and extracted with three 150 ml portions of ether. The 
three portions of ether were combined, placed over sodium 
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hydroxide pellets, and left to stand overnight in a liter flask 
in the refrigerator. 
The mixture was filtered by gravity and the ether removed 
by means of a rotary evaporator without heat. The mixture was 
then distilled under reduced pressure (0.1 mm), bp 143-6°. The 
yield of clear oil was llg (17.6% yield). Calculated for 
c11H15No3 : titrateable N, 6.69%. Found, 6.6%. 
The four (4) synthesized compounds were tested in cancerous 
C3H mice as previously described. The following results were 
observed. 
(1) 3-Indolylmethyl-bis(2,3-epoxypropyl)amine 
Tumor - Positive, but only a slight color was observed. 
Liver - Positive, but only a very slight color was observed. 
Muscle - Negative, no color was observed. 
(2) Sodium-3-2(3-indolyl)ethylamino propane sulfonate 
Tumor - Positive, a beautiful red color was observed. 
Liver - Negative, no color was observed. 
Muscle - Negative, no color was observed. 
(3) Methyl-2-furylmethyl-2,3-epoxypropyl amine 
Tumor - Negative, no color was observed. 
Liver - Negative, no color was observed. 
Muscle - Negative, no color was observed. 
(4) 2-Furylmethyf-bis{2,J-epoxypropyl)amine 
Tumor - Negative, no color was observed. 
Liver - Negative, no color was observed. 
Muscle - Negative, no color was observed. 
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The procedure for dissection and testing these compounds 
previously described proved rather tedious. Therefore, the 
following compounds were purchased and tested, in vitro, by 
the butyl nitrite-hydrochloric acid test with the results in-
dicated below. 















2-1ndoline Sodium Sulfonate 
l-Acetyl-2-Indoline Sodium sulfonate 
Pyrrole 








The basis of this present study is the possibility of 
getting alkylating agents selectively in the cancer cell. As 
was shown by A.G. Bachmann in 1965 (Potential Neoplasm Inhibitors), 
indole and certain indole derivatives are selectively absorbed 
in cancerous tissue at a pH slightly lower than that of a normal 
cell. 
The desired derivatives of indole were epihydrinamines, 
beta-chloroethylamines, and methanesulfonates. To make the 
epihydrinamines and beta-chloroethylamines as intermediates, 
it was necessary to have basic primary amino groups or basic 
secondary amino groups, preferably the latter. For the meth-
anesulfonates, alcohols were the intermediates. 
In some cases satisfactory preparations were not obtained 
for the products which are potential carcinolytic agents. The 
synthesis of the potential intermediates are given, however, as 
a guide to future work. Also, the chemical activity of some 
of the potential carcinolytic agents was so great that isolation 
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of the compound was not successful. In such cases derivatives 
were made which required as intermediates the desired active 
chemical. 





To a solution of 23.4g (0.2 mole) of indole-3-carbox-
aldehyde dissolved in 25 ml of methanol was added 16.7g 
(0.22 mole) of Q-butylamine. The mixture was heated over a 
hot-water bath for approximately 10 minutes. To this mixture 
was added slowly a solution of 16g sodium borohydride dis-
solved in 200ml of methanol, made basic with sodium hydroxide. 
The resulting mixture was allowed to stand overnight. The 
mixture was refluxed gently for one hour, cooled, and diluted 
to 500 ml with water. An oil formed which settled to the 
bottom of the container. The solution was acidified and the 
oil dissolved in the acidic layer. The solution was then 
extracted with two 250 ml portions of ether. The acidic 
layer was made basic with 6N sodium hydroxide and an oil 
which separated was extracted with 30 ml of ether. The ether 
was removed on a hot-water bath. The yield of the oil was 
12.2g (30% yield). Calculated for c13H1aN2 : titrateable N, 
6.93%. Found, 7.09%. 
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!!_-Butyl-3-indolylmethyl-2-(4-methylpiperizino)ethyl amine 
c: H~ ~ C'f-H1 
~H~J\, H e H4-,\_J-c H3 
To a solution of 12.2g (0.06 mole) of 3-Indolylmethyl-
butyl amine in 5 ml of methanol was added very slowly with 
swirling 17.4g (0.11 mole) of beta-chloroethyl methanesulfonate, 
and it was left to stand overnight. To this mixture was added 
slowly with stirring 5g (0.05 mole) of N-methylpiperazine. 
The reaction mixture was heated on a hot-water bath near 80° 
for about 20 minutes. Approximately 125 ml of 10% acetic acid 
was added and the mixture treat·ea with two 50 ml portions of 
ether. The aqueous-acid layers were treated with 6N sodium 
hydroxide solution, and a deep red oily layer separated. On 
treatment with 25 ml of ether, the product crystallized. The 
solution was filtered; the crystalline product was dissolved 
in dilute acetic acid and extracted with 6N $Odium hydroxide 
and extracted with ether. The crystalline product which pre-
cipitated was J.7g (23% yield). Calculated for c20H32N4: 
titrateable N, 12.80%. Found, 12.28%. 






A solution of 46.9g (0.40 mole) of indole in 240 ml of 
glacial acetic acid was chilled and stirred while 26.4g 
(0.44 mole) of isopropylamine was added. To this cold solution 
was -added a solution of 18.6g (0.416 mole) of acetaldehyde in 
80 ml of benzene. The mixture was allowed to stand at o0 • 
The reaction mixture was poured into Boo ml of ice-
water and 50 ml of ether. The ether layer was separated and 
extracted with two 125 ml po~tions of l~ potassium bisulfite. 
The combined ~queous solutions were washed with two 50 ml 
portions of .e_ther, then~de basic with lON sodium hydroxide; 
during addition of the alkali, the temperature was kept below 
25°. To promote crystallization. 100 ml of methylayclohexane 
was added, and the :mixture was allowed to stand. The precipi-
tate which formed ¥as filtered and recrystallized using 
. ~ethylcyclohexane. The yield of the crystalline product was 
35.0g (33% yield), mp 112-4°. Calculated for c13H18N2 : 
titrateable N, 6.93%. Found, 6.8%. 
Isopropyl-2,3-epoxypropylo((J-indolylethyl)amine 
-CH( CHJ )-~;CH{ CH3 ) 2 
~ 2 I H:;,o 
.H H2 
To.12.4g {0.13 mole ) of epichlorohydrin was added lOg 
(0.05 mole) of 3-(Isopropylaminoethlidene)-indole, and the 
mixture was allowed to stand over hot water (60-75°) for one-
ha_l.f hour. The reaction mixture was then stored in the 
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refrigerator for approximately four weeks. The viscous sub-
stance was acidified with 50 ml of 10% acetic acid. The acetic 
acid solution was extracted with 50 ml of ether. The aqueous 
portion was treated with excess 6N sodium hydroxide. The oily 
layer which separated was taken up in 25 ml of ether. To the 
mixture was added 10 ml of acetic anhydride, and it was allowed 
to stand about 15 minutes. An oil, the acetate of the amine, 
came out of solution and was drawn off. The solution was made 
strongly basic with 50% sodium hydroxide. An oil which rose to 
the top was extracted with 10 ml of ether. The ether was re-
moved by means of a rotary evaporator and a clear oil remained. 





I CH2N-CH2-CH2-CH2N(C2H5) 2 H A mixture of 12g (0.13 mole) of epichlorohydrin and lOg 
(0.05 mole) of 3-Indolylethylisopropylamine was heated in a 
hot-water bath (75°) for half an hour. The resulting red 
solution was dissolved in 50 ml of ether and extracted with 
lOOml of 15% acetic acid. The aqueous layer was made basic 
with 6N sodium hydroxide. The oil which separated was extracted 
with 25 ml of ether. To this solution was added 6g (0.046 mole) 
of diethylaminopropylamine and the resulting solution allowed 
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to stand for several minutes. The ether was evaporated and 
the residue was treated with excess dilute acetic acid. The 
solution was extracted with .50 ml of ether, and the e.ther 
layer was made basic with 6N sodium hydroxide, and the oil 
which separated was treated with dilute acetic acid. The pH 
of the solution was adjusted to 7, and the solution was extracted 
with 20 ml of ether. The aqueous layer was made basic with 
6N sodium hydroxide, and the oil which separated was dried and 
analyzed. Calculated for c23H40N4o: titrateable N, 10.82%. 
Found, 11.2%. 
3- [3-(hydroxy)piperidinomethyl indole] 
Q:J-c~QOH 
H 
To a solution of 4.5g (0.0.5 mole) of 3-hydroxypiperidine 
dissolved in 1.5 ml of acetic acid was added 7.5g (0.07.5 mole) 
of indole dissolved in 10 ml of acetic acid, keeping the 
temperature below 20°. To the cooled mixture was added slowly 
10 ml of formaldehyde keeping the temperature below 10°. The 
mixture was allowed to stand at room temperature for one hour 
and then poured slowly with swirling into 250 ml of ether. 
The mixture was poured into three (3) different 2.50 ml volumes 
of ether. Each time the ether was discarded. The aqueous 
layer was diluted with 100 ml of water and extracted again 
with 150 ml ether. Excess sodium hydroxide was added to the 
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aqueous layer, and a viscous oil appeared. The mixture was 
stirred well, but the product did not crystallize. The water 
was decanted off. The product was dissolved in ether, and the 
ether was vacuum evaporated. The residue crystallized. 




To 2.05g (0.009 mole) of 3-[3-(hydroxy)piperidinomethyl 
indole] in 10 ml of pyridine was added ll.5g (0.01 mole) of 
methanesulfonyl chloride, keeping the temperature at 0-10°. 
After addition was complete, the reaction mixture was allowed 
to come to room temperature and was poured into 200 ml of ice-
water containing 6 ml of 6N sodilllll hydroxide. An oil separated. 
The ice-water was decanted, and the oil was extracted with 
40 ml of ether. The ether was removed with suction under vacuum. 
A hot-water bath (95°) was used to speed up the evaporation. 
These conditions were too drastic, and the compound polymerized. 
In another similar run there was obtained an oil which gave 
the following analysis. Calculated for c15H20N204s: titrate-




To a solution of 4.5g (0.05 mole) of 4-hydroxypiperidine 
dissolved in 15 ml of acetic acid was added 7.5g (0.075 mole) 
of indole dissolved in 10 ml of acetic acid, keeping the 
temperature below 20°. To the cooled mixture was added slowly 
0 10 ml of formaldehyde keeping the temperature below 10 . The 
mixture was allowed to stand at room temperature for three (3) 
hours and then poured into two (2) different 250 volumes of 
ether as the flask was swirled. Each time the ether was 
discarded. To the oily product was added 250 ml of water and 
25 ml of acetic acid. The mixture was extracted with three (3) 
125 ml volumes of ether, each time discarding the ether. The 
aqueous layer was made basic, and the oil which separated was 
extracted with 50 ml of ether. The ether was filtered, evap-
orated, and an-&ily product was obtained. Calculated for 




In a similar manner in the run with 0.52g (0.0023 mole) 
of 3-(4-hydroxypiperidino indole} in lOml of pyridine and 
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o.34g (0.003 mole) of methanesulfonylchloride, the product 
polymerized. In another similar run there was obtained an 
oil which gave the following analysis. Calculated for 




The purity of all of the compounds prepared in this work 
was determined by titration of the basic nitrogen atom(s) using 
glacial acetic acid as solvent and 0.0903N perchloric acid in 
glacial acetic acid as the titrant. 85 The following compounds, 
for example, would contain: 
O::J-CH2CH2N( CH2-~H2 } 2 
R 
one titrateable nitrogen atom 
Equipment: Beclanen Glass Electrode pH meter 
Reagents: Reagent grade glacial acetic acid, 0.0903N 
perchloric acid in glacial acetic acid. 
Procedure: A sample ranging from 0.05g-O.lg is weighed into 
a 250 ml beaker. '.Ihe sample is dissolved in 35-50 ml of 
glacial acetic acid. Using a pH meter to follow the change 
in potential of the solution, the sample is titrated with 
perchloric acid in glacial acetic acid. Increments of 0.10 ml 
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are added to the solution until the endpoint is approached. 
The perchloric in glacial acetic acid is then added in 
increments of 0.05 ml and the endpoint is indicated by the 
greatest change in potential per O.OS ml increment of acid. 
Calculations: 
Molecular Weight = ~-A_..x;,.._;..w~t~·--__;;;s~a-m~p~l~e_...x;.,_;;l~O~O~O;,....;..~ 
ml acid x N of acid 
%Nitrogen= ~-A __ x ____ l4 .......... 0~_x ___ l_O_O __ ~ 
Molecular weight 
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